We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$224M
Cap. Flow
+$107M
Cap. Flow %
6.86%
Top 10 Hldgs %
23.64%
Holding
660
New
197
Increased
199
Reduced
106
Closed
124

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
3
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$9.92M
4
HSY icon
Hershey
HSY
+$8.28M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.11M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$11.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.4M
3
INCY icon
Incyte
INCY
+$9.85M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$8.36M
5
BBY icon
Best Buy
BBY
+$8.26M

Sector Composition

Rank Sector Weight
1 Technology 18.73%
2 Healthcare 12.12%
3 Financials 9.32%
4 Consumer Staples 9.11%
5 Consumer Discretionary 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
501
Puma Biotechnology
PBYI
$454M
– –
-46,200
Closed -$324K
PLTK icon
502
Playtika
PLTK
$1.12B
– –
-35,800
Closed -$989K
PRGS icon
503
Progress Software
PRGS
$1.76B
– –
-12,500
Closed -$615K
PUMP icon
504
ProPetro Holding
PUMP
$1.35B
– –
-23,100
Closed -$200K
QCRH icon
505
QCR Holdings
QCRH
$1.7B
– –
-6,100
Closed -$314K
QDEL icon
506
QuidelOrtho
QDEL
$838M
– –
-7,300
Closed -$1.03M
QGEN icon
507
Qiagen
QGEN
$8.72B
– –
-62,688
Closed -$3.44M
RCKY icon
508
Rocky Brands
RCKY
$369M
– –
-9,200
Closed -$438K
REGN icon
509
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-18,835
Closed -$11.4M
REYN icon
510
Reynolds Consumer Products
REYN
$5.59B
– –
-36,000
Closed -$984K
RGEN icon
511
Repligen
RGEN
$9.25B
– –
-3,000
Closed -$867K
RIGL icon
512
Rigel Pharmaceuticals
RIGL
$750M
– –
-22,060
Closed -$801K
RILY icon
513
BRC Group Holdings
RILY
$289M
– –
-9,500
Closed -$561K
RUSHA icon
514
Rush Enterprises Class A
RUSHA
$6.22B
– –
-20,700
Closed -$623K
RVP icon
515
Retractable Technologies
RVP
$20.1M
– –
-10,000
Closed -$110K
SB icon
516
Safe Bulkers
SB
$774M
– –
-174,600
Closed -$903K
SHC icon
517
Sotera Health
SHC
$5.38B
– –
-12,600
Closed -$329K
SIBN icon
518
SI-BONE Inc
SIBN
$834M
– –
-10,100
Closed -$216K
SIGA icon
519
SIGA Technologies
SIGA
$219M
– –
-36,700
Closed -$271K
SLQT icon
520
SelectQuote
SLQT
$121M
– –
-12,900
Closed -$167K
SONY icon
521
Sony
SONY
$138B
– –
-51,670
Closed -$1.14M
SPSC icon
522
SPS Commerce
SPSC
$2.64B
– –
-2,200
Closed -$355K
SSD icon
523
Simpson Manufacturing
SSD
$8.16B
– –
-3,500
Closed -$374K
SYBT icon
524
Stock Yards Bancorp
SYBT
$2.6B
– –
-5,800
Closed -$340K
TAK icon
525
Takeda Pharmaceutical
TAK
$55.7B
– –
-127,237
Closed -$2.08M
19 20
21
22 23

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return

Summit Global Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Summit Global Investments held 660 positions worth $1.56B, up 17% from $1.33B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Summit Global Investments deployed $107M of net new capital in Q4 2021, opening 197 new positions and adding to 199 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuit, an estimated $11.9M trimmed.

  • Summit Global Investments's largest Q4 2021 buy was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.
  • Summit Global Investments added most to Bristol-Myers Squibb in Q4 2021, an estimated $17.9M increase.
  • Summit Global Investments's biggest Q4 2021 reduction was Intuit, cutting an estimated $11.9M.
  • Summit Global Investments fully exited Regeneron Pharmaceuticals in Q4 2021, selling an estimated $11.4M.
  • Summit Global Investments's ten largest holdings make up 24% of its $1.56B portfolio in Q4 2021.
  • Summit Global Investments opened 197 new positions and closed 124 in Q4 2021.
  • Summit Global Investments's portfolio value rose 17% quarter-over-quarter to $1.56B.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.